This project studies the role of abnormal NF-κB activation in B cell lymphomas, focusing on its contribution to malignant transformation, therapy resistance, and disease progression. The aim is to determine whether lymphoma cells remain addicted to continuous NF-κB activity and how it influences tumor growth and the microenvironment. Using advanced preclinical models and genetic mouse models, the project will identify critical moments and locations where NF-κB is essential. The goal is to uncover molecular targets for intervention, potentially advancing the therapeutic use of NF-κB inhibitors and improving treatment options.
PRINCIPAL INVESTIGATOR
Project Interactions
-
A03
LUBAC and its enzymatic activities in the development and therapy of ABC-diffuse large B-cell lymphoma
Prof. Dr. rer. nat. Henning Walczak, Dr. rer. nat. Gianmaria Liccardi -
A04
Role of CASP8/cFLIP dimer in controlling lymphomagenesis
Prof. Dr. rer. nat. Hamid Kashkar, Dr. rer. nat. Alessandro Annibaldi -
B01
Dissecting the role of tyrosine kinases as key regulators and therapeutic targets in the microenvironment of chronic lymphocytic leukemia
Prof. Dr. med. Michael Hallek, Dr. med. Laura Beckmann